首页 > 最新文献

Advances in Mind-Body Medicine最新文献

英文 中文
Effective Management of Type-2 Diabetes Mellitus with Unani Medications: A Case Report. 用尤那尼药物有效治疗 2 型糖尿病:病例报告
Q3 Medicine Pub Date : 2024-09-01
Faiza Nasir, Malik Itrat, Fauzia Shahabuddin, Sadia Nikhat
<p><strong>Introduction: </strong>Diabetes mellitus (DM) presents a formidable global health challenge, with conventional treatments often accompanied by limitations and adverse effects. Moreover, accessibility and affordability of conventional treatments remain barriers for many individuals, particularly in low-resource settings. Hence, there is a compelling need to explore alternative therapeutic modalities, such as Unani medicine, which offer the potential for effective management of type 2 diabetes mellitus (T2DM) while potentially mitigating these drawbacks.</p><p><strong>Case presentation: </strong>A 35-year-old female patient presented with symptoms including fatigue, increased thirst, frequent urination, and a burning sensation in both feet. Her medical history revealed Type 2 Diabetes Mellitus (T2DM), with fasting blood glucose (FBS) levels at 276 mg/dl, postprandial blood glucose levels (PPBS) at 380 mg/dl, and a glycated haemoglobin percentage (HbA1c) of 11.2%. Initially prescribed with a combination of glimepiride (1mg) and metformin (500mg) twice daily, she discontinued the treatment due to discomfort. The patient was diagnosed with Dhayābῑtus Shakari and subsequently treated with Unani medications including Qurs Ziabetus (tablets), Zulal Ziabetus (decant), Safoof Darchini (powder), and Arq Zeera (distillate), commonly used in Unani Medicine for T2DM. Additionally, she received dietary recommendations and was advised to engage in a daily 30-minute walk. The patient underwent follow-up assessments every 2 weeks for a total of 12 weeks. Over this period, the patient exhibited positive responses to treatment, evidenced by notable improvements in glycaemic control. Specifically, fasting blood glucose (FBS) levels decreased to 139 mg/dl, postprandial blood glucose (PPBS) levels dropped to 179 mg/dl, and glycated hemoglobin percentage (HbA1c) decreased to 8.7%. Additionally, there was a significant amelioration in overall symptoms, as evaluated through the Asian Diabetes Quality of Life questionnaire scores and Diabetic Neuropathy Symptom score. At baseline, the AsianDQOL score indicated poor quality of life at 47, which notably improved to 85 post-treatment, indicating a shift towards a good quality of life. Furthermore, the Diabetic Neuropathy Symptom score reduced from 3 at baseline to 0 at the conclusion of treatment, indicative of alleviated pain and burning sensation in the feet.</p><p><strong>Conclusion: </strong>This case report highlights the potential effectiveness of Unani medications in managing T2DM, suggesting its viability as a treatment option within a comprehensive diabetes management strategy. The patient's positive response underscores Unani medicine's potential not only as a complementary treatment but also as an integrative approach. However, to substantiate these findings and explore the integration of Unani treatments with conventional therapies, further research, including controlled clinical trials, is imperative.
导言:糖尿病(DM)是一项严峻的全球健康挑战,传统治疗方法往往存在局限性和不良反应。此外,传统疗法的可及性和可负担性仍然是许多人的障碍,尤其是在资源匮乏的环境中。因此,亟需探索替代治疗方法,如尤那尼医学,它有可能在有效控制 2 型糖尿病(T2DM)的同时减轻这些弊端:一位 35 岁的女性患者出现了疲劳、口渴、尿频和双脚烧灼感等症状。她的病史显示她患有 2 型糖尿病(T2DM),空腹血糖(FBS)水平为 276 mg/dl,餐后血糖(PPBS)水平为 380 mg/dl,糖化血红蛋白百分比(HbA1c)为 11.2%。起初,她接受格列美脲(1 毫克)和二甲双胍(500 毫克)联合治疗,每天两次,但因不适而中断治疗。患者被诊断为 Dhayābῑtus Shakari,随后接受了乌纳尼药物治疗,包括 Qurs Ziabetus(片剂)、Zulal Ziabetus(倾析剂)、Safoof Darchini(粉剂)和 Arq Zeera(蒸馏物),这些药物在乌纳尼医学中常用于治疗 T2DM。此外,她还接受了饮食建议,并被建议每天进行 30 分钟的散步。患者每两周接受一次随访评估,总共持续了 12 周。在此期间,患者对治疗表现出积极的反应,血糖控制明显改善。具体来说,空腹血糖(FBS)水平降至 139 毫克/分升,餐后血糖(PPBS)水平降至 179 毫克/分升,糖化血红蛋白百分比(HbA1c)降至 8.7%。此外,通过亚洲糖尿病患者生活质量问卷评分和糖尿病神经病变症状评分评估,患者的总体症状也有明显改善。基线时,AsianDQOL 评分显示生活质量较差,为 47 分,治疗后明显提高到 85 分,表明生活质量向好的方向转变。此外,糖尿病神经病变症状评分从基线时的 3 分降至治疗结束时的 0 分,表明脚部疼痛和烧灼感有所减轻:本病例报告强调了尤那尼药物治疗 T2DM 的潜在疗效,表明其作为糖尿病综合管理策略中的一种治疗方案的可行性。患者的积极反应凸显了尤那尼医学不仅作为一种辅助治疗方法,而且作为一种综合治疗方法的潜力。然而,为了证实这些研究结果,并探索将乌纳尼疗法与传统疗法相结合,进一步的研究,包括对照临床试验,势在必行。强调多学科方法的重要性,未来的研究应调查乌纳尼医药在T2DM治疗中的作用机制、安全性和长期疗效,以优化糖尿病护理。
{"title":"Effective Management of Type-2 Diabetes Mellitus with Unani Medications: A Case Report.","authors":"Faiza Nasir, Malik Itrat, Fauzia Shahabuddin, Sadia Nikhat","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Diabetes mellitus (DM) presents a formidable global health challenge, with conventional treatments often accompanied by limitations and adverse effects. Moreover, accessibility and affordability of conventional treatments remain barriers for many individuals, particularly in low-resource settings. Hence, there is a compelling need to explore alternative therapeutic modalities, such as Unani medicine, which offer the potential for effective management of type 2 diabetes mellitus (T2DM) while potentially mitigating these drawbacks.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Case presentation: &lt;/strong&gt;A 35-year-old female patient presented with symptoms including fatigue, increased thirst, frequent urination, and a burning sensation in both feet. Her medical history revealed Type 2 Diabetes Mellitus (T2DM), with fasting blood glucose (FBS) levels at 276 mg/dl, postprandial blood glucose levels (PPBS) at 380 mg/dl, and a glycated haemoglobin percentage (HbA1c) of 11.2%. Initially prescribed with a combination of glimepiride (1mg) and metformin (500mg) twice daily, she discontinued the treatment due to discomfort. The patient was diagnosed with Dhayābῑtus Shakari and subsequently treated with Unani medications including Qurs Ziabetus (tablets), Zulal Ziabetus (decant), Safoof Darchini (powder), and Arq Zeera (distillate), commonly used in Unani Medicine for T2DM. Additionally, she received dietary recommendations and was advised to engage in a daily 30-minute walk. The patient underwent follow-up assessments every 2 weeks for a total of 12 weeks. Over this period, the patient exhibited positive responses to treatment, evidenced by notable improvements in glycaemic control. Specifically, fasting blood glucose (FBS) levels decreased to 139 mg/dl, postprandial blood glucose (PPBS) levels dropped to 179 mg/dl, and glycated hemoglobin percentage (HbA1c) decreased to 8.7%. Additionally, there was a significant amelioration in overall symptoms, as evaluated through the Asian Diabetes Quality of Life questionnaire scores and Diabetic Neuropathy Symptom score. At baseline, the AsianDQOL score indicated poor quality of life at 47, which notably improved to 85 post-treatment, indicating a shift towards a good quality of life. Furthermore, the Diabetic Neuropathy Symptom score reduced from 3 at baseline to 0 at the conclusion of treatment, indicative of alleviated pain and burning sensation in the feet.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This case report highlights the potential effectiveness of Unani medications in managing T2DM, suggesting its viability as a treatment option within a comprehensive diabetes management strategy. The patient's positive response underscores Unani medicine's potential not only as a complementary treatment but also as an integrative approach. However, to substantiate these findings and explore the integration of Unani treatments with conventional therapies, further research, including controlled clinical trials, is imperative. ","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"38 4","pages":"8-13"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Applications of Neem (Azadirachta indica): A Narrative Review. 印楝(Azadirachta indica)的治疗应用:叙述性综述。
Q3 Medicine Pub Date : 2024-09-01
S Mehnaz, Yasmeen Shamsi, Md Wasi Akhtar, Sujata Mohanty, Sayeed Ahmad

It is no surprise that nature has provided us with many therapeutic compounds for thousands of years. Throughout history, plants and their derivatives have been used orally and locally to treat most of the diseases. In addition to providing a wealth of health benefits, Azadirachta indica stands out among all of them as one of the most universal and prolific trees. Since antiquity, this medicinal plant has been used in the Unani System of Medicine as well as in other traditional systems of medicine (Ayurveda, Homeopathic, Chinese, and European "Materia Medica") to treat a wide range of diseases. Almost every part of the tree can be used as medicine, including its leaves, flowers, seeds, fruits, roots, and bark, both locally and systemically after being properly processed in pharmaceutical industries. Apart from treating various skin ailments like dermatitis, eczema, acne, and fungal and bacterial infections, it also exhibits anti-malarial, anticancer, antifertility, antioxidant, antidiabetic, anti-inflammatory, hepatoprotective, neuroprotective, and wound healing properties. In modern times, it is also used in cosmetics, toiletries, and pharmaceutical products. The purpose of this review is to gather all the information available about Azadirachta indica, including its distribution, botanical description, commercial use, and medicinal properties.

几千年来,大自然为我们提供了许多治疗化合物,这并不奇怪。纵观历史,植物及其衍生物一直被用于口服和局部治疗大多数疾病。Azadirachta indica 除了具有丰富的保健功效外,还是最普遍、最多产的树木之一。自古以来,这种药用植物就被用于乌纳尼医学体系以及其他传统医学体系(阿育吠陀、顺势疗法、中药和欧洲《本草纲目》),用于治疗各种疾病。经制药业适当加工后,几乎树的每个部分都可用作药物,包括树叶、花、种子、果实、根和树皮。除了治疗皮炎、湿疹、痤疮、真菌和细菌感染等各种皮肤病外,它还具有抗疟疾、抗癌、抗生育、抗氧化、抗糖尿病、抗炎、保护肝脏、保护神经和伤口愈合等特性。在现代,它还被用于化妆品、洗浴用品和医药产品。本综述旨在收集有关 Azadirachta indica 的所有信息,包括其分布、植物学描述、商业用途和药用特性。
{"title":"Therapeutic Applications of Neem (Azadirachta indica): A Narrative Review.","authors":"S Mehnaz, Yasmeen Shamsi, Md Wasi Akhtar, Sujata Mohanty, Sayeed Ahmad","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>It is no surprise that nature has provided us with many therapeutic compounds for thousands of years. Throughout history, plants and their derivatives have been used orally and locally to treat most of the diseases. In addition to providing a wealth of health benefits, Azadirachta indica stands out among all of them as one of the most universal and prolific trees. Since antiquity, this medicinal plant has been used in the Unani System of Medicine as well as in other traditional systems of medicine (Ayurveda, Homeopathic, Chinese, and European \"Materia Medica\") to treat a wide range of diseases. Almost every part of the tree can be used as medicine, including its leaves, flowers, seeds, fruits, roots, and bark, both locally and systemically after being properly processed in pharmaceutical industries. Apart from treating various skin ailments like dermatitis, eczema, acne, and fungal and bacterial infections, it also exhibits anti-malarial, anticancer, antifertility, antioxidant, antidiabetic, anti-inflammatory, hepatoprotective, neuroprotective, and wound healing properties. In modern times, it is also used in cosmetics, toiletries, and pharmaceutical products. The purpose of this review is to gather all the information available about Azadirachta indica, including its distribution, botanical description, commercial use, and medicinal properties.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"38 4","pages":"14-18"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated Yoga and Naturopathy Intervention on Glycemic Profile and Autonomic Variables in Co-Existence of Diabetes Mellitus with Hypertension: A Two-Arm Observational Study. 瑜伽和自然疗法综合干预对糖尿病合并高血压患者血糖谱和自主神经变量的影响:双臂观察研究》。
Q3 Medicine Pub Date : 2024-09-01
S Lekshmi Mohan, K J Sujatha, Prashanth Shetty, H L Nanjeshgowda

Background: Diabetes Mellitus coexisting with hypertension has received significant global attention and remains a public health challenge in the past two decades. The states of hyperinsulinemia and insulin resistance have been postulated as causes or consequences of hypertension. Evidence shows that alternative systems of medicine can play a significant role in achieving glycemic control. This study aimed to compare and evaluate the impact of yoga and naturopathy-based lifestyles on patients with diabetes mellitus and diabetes mellitus with hypertension.

Methods: Sixty subjects were recruited into two groups, group 1 (diabetes mellitus with hypertension) and group 2 (diabetes mellitus) based on the inclusion and exclusion criteria. Both the groups underwent naturopathy and yoga intervention for ten days. The glycemic profile and heart rate variability (HRV) of the patients were assessed at the baseline and 10 days after the intervention.

Results: Study resulted in a significant change in both time domain and frequency domain variables (HRV, FBS, and PPBS) in both group 1 and group 2 (P < .05, for all) but the mean difference was more in group 2 with a significant difference between the two groups, P < .05. The diastolic blood pressure significantly decreased only in group 2, whereas the systolic blood pressure decreased in both groups without any difference between the two groups.

Conclusion: The results of the present study show that integrated yoga and naturopathy management significantly help in glycemic control and autonomic functions in both groups.

背景:在过去二十年里,糖尿病与高血压并存已受到全球的高度关注,并仍是一项公共卫生挑战。高胰岛素血症和胰岛素抵抗被认为是高血压的原因或后果。有证据表明,替代医学体系在实现血糖控制方面可以发挥重要作用。本研究旨在比较和评估瑜伽和自然疗法生活方式对糖尿病患者和糖尿病合并高血压患者的影响:根据纳入和排除标准,将 60 名受试者分为两组,即第 1 组(糖尿病合并高血压)和第 2 组(糖尿病)。两组均接受为期十天的自然疗法和瑜伽干预。分别在基线和干预后 10 天对患者的血糖状况和心率变异性(HRV)进行评估:研究结果表明,第一组和第二组的时域和频域变量(心率变异性、FBS 和 PPBS)都发生了显著变化(P < .05),但第二组的平均差异更大,两组之间差异显著,P < .05。只有第 2 组的舒张压明显下降,而两组的收缩压均下降,两组间无差异:本研究结果表明,瑜伽和自然疗法综合疗法对两组患者的血糖控制和自律神经功能均有明显帮助。
{"title":"Integrated Yoga and Naturopathy Intervention on Glycemic Profile and Autonomic Variables in Co-Existence of Diabetes Mellitus with Hypertension: A Two-Arm Observational Study.","authors":"S Lekshmi Mohan, K J Sujatha, Prashanth Shetty, H L Nanjeshgowda","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Diabetes Mellitus coexisting with hypertension has received significant global attention and remains a public health challenge in the past two decades. The states of hyperinsulinemia and insulin resistance have been postulated as causes or consequences of hypertension. Evidence shows that alternative systems of medicine can play a significant role in achieving glycemic control. This study aimed to compare and evaluate the impact of yoga and naturopathy-based lifestyles on patients with diabetes mellitus and diabetes mellitus with hypertension.</p><p><strong>Methods: </strong>Sixty subjects were recruited into two groups, group 1 (diabetes mellitus with hypertension) and group 2 (diabetes mellitus) based on the inclusion and exclusion criteria. Both the groups underwent naturopathy and yoga intervention for ten days. The glycemic profile and heart rate variability (HRV) of the patients were assessed at the baseline and 10 days after the intervention.</p><p><strong>Results: </strong>Study resulted in a significant change in both time domain and frequency domain variables (HRV, FBS, and PPBS) in both group 1 and group 2 (P < .05, for all) but the mean difference was more in group 2 with a significant difference between the two groups, P < .05. The diastolic blood pressure significantly decreased only in group 2, whereas the systolic blood pressure decreased in both groups without any difference between the two groups.</p><p><strong>Conclusion: </strong>The results of the present study show that integrated yoga and naturopathy management significantly help in glycemic control and autonomic functions in both groups.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"38 4","pages":"19-24"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive In-Patient Neuro-rehabilitation: Harnessing Yoga's Potential - A Pilot Study in Germany. 综合住院神经康复:利用瑜伽的潜力--德国的一项试点研究。
Q3 Medicine Pub Date : 2024-09-01
B C Ashwini, R Nagarathna, C Garner, Ashween Bilagi, Shreedhar Palukuru
<p><strong>Background: </strong>Neurological diseases require rehabilitation due to the disabling effects they induce, yet cost and therapist availability make long-term therapy difficult. However, innovative, cost-effective strategies that cater to patients' physical and mental requirements are vital to address this gap in care. Incorporating Yoga into in-patient neuro-rehabilitation holds promise as a complementary approach to enhance physical and mental recovery for individuals in a German neurological rehabilitation hospital. This study explores the potential benefits of integrating Yoga within the multimodal care framework, shedding light on its role in improving patient outcomes and overall well-being.</p><p><strong>Objectives: </strong>To study the effect of integrated yoga therapy and multimodal rehabilitation techniques in the neuro-rehabilitation of Multiple Sclerosis, Stroke, and others in an in-patient setting.</p><p><strong>Design and setting: </strong>A single group pre-post study was conducted at a neurological rehabilitation centre- KWA-Klinik, Stift Rottal, Bad Griesbach, Germany. Twenty patients (11 female and nine male, age 54.4 ± 9.50 years) with different neurological diseases (12-Multiple Sclerosis, 3-Stroke, 5- others) volunteered to participate in the study.</p><p><strong>Intervention: </strong>The integrated yoga intervention was designed by experts from Yoga and neurology to suit neuro-rehabilitation patients. Yoga intervention included Breathing practices, yogic loosening practices, Rapid breathing (Kapalabhati), Alternate nostril breathing (Nadishuddi Pranayama), Physical postures (Asanas), and Relaxation techniques. Participants underwent yoga training for one hour daily, five days a week, for three weeks, along with other conventional rehabilitation procedures.</p><p><strong>Outcome measures: </strong>The Pain Analog Scale and Spasticity Analog Scale were used to determine the extent of the problem. Barthel Index, Timed up and go Test, and Hand Grip Strength were used to determine the baseline functioning of a patient. Hospital Anxiety and Depression Scale (HADS) to assess anxiety and depression symptoms in patients.WHOQOL-BREF questionnaire used to assess QoL.</p><p><strong>Results: </strong>There was a significant reduction in pain (66.97%, P = .001), spasticity (64.47%, P = .001), and anxiety scores (29.05%, P = .02). There is no significant decrease in depression scores (21.86%, P = .065). Improvement in Barthel index (10.38%, P < .001), timed up and go Test (11.63%, P = .001), and physical (4.92%, P = .031), psychological (4.79%, P = .036) and environmental domains (9.12%, P = .001) of WHOQOL-BREF. The results indicate that yoga therapy can effectively address common and debilitating symptoms associated with neurological disorders. Along with the improvement in daily living activities, mobility, and overall quality of life for patients with neurological conditions.</p><p><strong>Conclusion: </strong>Incorporatin
背景:神经系统疾病会导致残疾,因此需要进行康复治疗,但费用和治疗师的可用性使长期治疗变得困难。然而,满足患者身心需求的创新性、成本效益高的策略对于解决这一护理缺口至关重要。在一家德国神经康复医院,将瑜伽融入住院神经康复治疗有望成为一种辅助方法,促进患者的身心康复。本研究探讨了将瑜伽融入多模式护理框架的潜在益处,揭示了瑜伽在改善患者疗效和整体健康方面的作用:研究综合瑜伽疗法和多模式康复技术在多发性硬化症、中风和其他住院病人神经康复中的效果:在德国巴特格里斯巴赫的一家神经康复中心(KWA-Klinik, Stift Rottal, Bad Griesbach)进行了一项单组前后对比研究。20 名患有不同神经系统疾病的患者(11 名女性,9 名男性,年龄为 54.4 ± 9.50 岁)(12 名多发性硬化症患者,3 名中风患者,5 名其他患者)自愿参加了此次研究:综合瑜伽干预由瑜伽和神经病学专家设计,适合神经康复患者。瑜伽干预包括呼吸练习、瑜伽松弛练习、快速呼吸(Kapalabhati)、鼻孔交替呼吸(Nadishuddi Pranayama)、体位法(Asanas)和放松技巧。参与者每天进行一小时的瑜伽训练,每周五天,为期三周,同时接受其他常规康复治疗:疼痛类比量表和痉挛类比量表用于确定问题的严重程度。巴特尔指数、定时起立行走测试和手握力用于确定患者的基线功能。使用医院焦虑抑郁量表(HADS)评估患者的焦虑和抑郁症状:结果:疼痛(66.97%,P = .001)、痉挛(64.47%,P = .001)和焦虑评分(29.05%,P = .02)明显减少。抑郁评分没有明显下降(21.86%,P = .065)。巴特尔指数(10.38%,P < .001)、定时起立和走动测试(11.63%,P = .001)、WHOQOL-BREF 的身体(4.92%,P = .031)、心理(4.79%,P = .036)和环境领域(9.12%,P = .001)均有改善。研究结果表明,瑜伽疗法能有效解决与神经系统疾病相关的常见衰弱症状。结论:将瑜伽疗法纳入神经系统疾病的治疗中,可以改善神经系统疾病患者的日常生活活动、活动能力和整体生活质量:事实证明,将瑜伽融入德国一家神经康复医院住院病人的神经康复疗程是可行且有利的。将瑜伽课程无缝纳入结构化康复计划证明了这种整合的实用性。未来的研究应侧重于探索瑜伽与其他神经康复辅助疗法的长期效果。
{"title":"Comprehensive In-Patient Neuro-rehabilitation: Harnessing Yoga's Potential - A Pilot Study in Germany.","authors":"B C Ashwini, R Nagarathna, C Garner, Ashween Bilagi, Shreedhar Palukuru","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Neurological diseases require rehabilitation due to the disabling effects they induce, yet cost and therapist availability make long-term therapy difficult. However, innovative, cost-effective strategies that cater to patients' physical and mental requirements are vital to address this gap in care. Incorporating Yoga into in-patient neuro-rehabilitation holds promise as a complementary approach to enhance physical and mental recovery for individuals in a German neurological rehabilitation hospital. This study explores the potential benefits of integrating Yoga within the multimodal care framework, shedding light on its role in improving patient outcomes and overall well-being.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To study the effect of integrated yoga therapy and multimodal rehabilitation techniques in the neuro-rehabilitation of Multiple Sclerosis, Stroke, and others in an in-patient setting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design and setting: &lt;/strong&gt;A single group pre-post study was conducted at a neurological rehabilitation centre- KWA-Klinik, Stift Rottal, Bad Griesbach, Germany. Twenty patients (11 female and nine male, age 54.4 ± 9.50 years) with different neurological diseases (12-Multiple Sclerosis, 3-Stroke, 5- others) volunteered to participate in the study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Intervention: &lt;/strong&gt;The integrated yoga intervention was designed by experts from Yoga and neurology to suit neuro-rehabilitation patients. Yoga intervention included Breathing practices, yogic loosening practices, Rapid breathing (Kapalabhati), Alternate nostril breathing (Nadishuddi Pranayama), Physical postures (Asanas), and Relaxation techniques. Participants underwent yoga training for one hour daily, five days a week, for three weeks, along with other conventional rehabilitation procedures.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;The Pain Analog Scale and Spasticity Analog Scale were used to determine the extent of the problem. Barthel Index, Timed up and go Test, and Hand Grip Strength were used to determine the baseline functioning of a patient. Hospital Anxiety and Depression Scale (HADS) to assess anxiety and depression symptoms in patients.WHOQOL-BREF questionnaire used to assess QoL.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;There was a significant reduction in pain (66.97%, P = .001), spasticity (64.47%, P = .001), and anxiety scores (29.05%, P = .02). There is no significant decrease in depression scores (21.86%, P = .065). Improvement in Barthel index (10.38%, P &lt; .001), timed up and go Test (11.63%, P = .001), and physical (4.92%, P = .031), psychological (4.79%, P = .036) and environmental domains (9.12%, P = .001) of WHOQOL-BREF. The results indicate that yoga therapy can effectively address common and debilitating symptoms associated with neurological disorders. Along with the improvement in daily living activities, mobility, and overall quality of life for patients with neurological conditions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Incorporatin","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"38 4","pages":"25-30"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Vakrasana on Blood Glucose Levels in Type 2 Diabetes Mellitus: A Randomized Controlled Study. Vakrasana 对 2 型糖尿病患者血糖水平的影响:随机对照研究
Q3 Medicine Pub Date : 2024-09-01
G Tamilselvi, A Mooventhan, S Iswarya, L Nivethitha, S T Venkateshwaran

Background: Diabetes mellitus is one of the most prevalent metabolic diseases. Literature suggests that yoga including a group of asanas reduces blood glucose and glycated hemoglobin levels in type 2 diabetes mellitus (T2DM). However, to the best of our knowledge, no known study evaluated the effects of a single asana (i.e., Vakrasana) in T2DM.

Objective: This study aimed to determine the effect of Vakrasanana on blood glucose levels in T2DM patients.

Materials and methods: Sixty T2DM patients aged 51.12 ± 6.43 years were randomly (1:1 ratio) allocated to yoga group (YG) and control group (CG). YG was asked to perform only one session of Vakrasana, while the CG was on rest in a sitting posture for 10 minutes. Random blood glucose (RBG) levels were assessed before and after the intervention.

Results: Within-group analysis showed a significant reduction in RBG levels in YG (P < .001; Effect size (d) = 0.203), while a significant increase in RBG was observed in CG (P < .001; Effect size (d) = 0.077), compared to the respective pre-test assessments. Whereas the between-groups analysis did not show a significant difference in RBG levels between the two groups (z = 1.597; P = 0.110). However, YG had a small effect size (Effect size (d) = 0.288) in reducing RBG levels compared to CG.

Conclusion: Ten minutes of Vakrasana has some positive effect in reducing blood glucose levels, unlike rest in sitting posture in patients with T2DM. However, further studies are required to validate the findings of this study.

背景:糖尿病是最常见的代谢性疾病之一。文献表明,包括一组体式在内的瑜伽能降低 2 型糖尿病(T2DM)患者的血糖和糖化血红蛋白水平。然而,据我们所知,还没有一项研究评估了单一体式(即 Vakrasana)对 T2DM 的影响:本研究旨在确定 Vakrasanana 对 T2DM 患者血糖水平的影响:将 60 名年龄为 51.12 ± 6.43 岁的 T2DM 患者随机(1:1 比例)分配到瑜伽组(YG)和对照组(CG)。YG 组只需进行一次 Vakrasana,而 CG 组则保持坐姿休息 10 分钟。干预前后对随机血糖(RBG)水平进行了评估:组内分析显示,与测试前的评估结果相比,YG 的随机血糖水平明显下降(P < .001;效应大小 (d) = 0.203),而 CG 的随机血糖水平则明显上升(P < .001;效应大小 (d) = 0.077)。而组间分析显示,两组之间的 RBG 水平没有明显差异(z = 1.597;P = 0.110)。然而,与 CG 相比,YG 在降低 RBG 水平方面的影响较小(影响大小 (d) = 0.288):结论:与坐姿休息不同,十分钟的 Vakrasana 对降低 T2DM 患者的血糖水平有一定的积极作用。然而,还需要进一步的研究来验证这项研究的结果。
{"title":"Effect of Vakrasana on Blood Glucose Levels in Type 2 Diabetes Mellitus: A Randomized Controlled Study.","authors":"G Tamilselvi, A Mooventhan, S Iswarya, L Nivethitha, S T Venkateshwaran","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus is one of the most prevalent metabolic diseases. Literature suggests that yoga including a group of asanas reduces blood glucose and glycated hemoglobin levels in type 2 diabetes mellitus (T2DM). However, to the best of our knowledge, no known study evaluated the effects of a single asana (i.e., Vakrasana) in T2DM.</p><p><strong>Objective: </strong>This study aimed to determine the effect of Vakrasanana on blood glucose levels in T2DM patients.</p><p><strong>Materials and methods: </strong>Sixty T2DM patients aged 51.12 ± 6.43 years were randomly (1:1 ratio) allocated to yoga group (YG) and control group (CG). YG was asked to perform only one session of Vakrasana, while the CG was on rest in a sitting posture for 10 minutes. Random blood glucose (RBG) levels were assessed before and after the intervention.</p><p><strong>Results: </strong>Within-group analysis showed a significant reduction in RBG levels in YG (P < .001; Effect size (d) = 0.203), while a significant increase in RBG was observed in CG (P < .001; Effect size (d) = 0.077), compared to the respective pre-test assessments. Whereas the between-groups analysis did not show a significant difference in RBG levels between the two groups (z = 1.597; P = 0.110). However, YG had a small effect size (Effect size (d) = 0.288) in reducing RBG levels compared to CG.</p><p><strong>Conclusion: </strong>Ten minutes of Vakrasana has some positive effect in reducing blood glucose levels, unlike rest in sitting posture in patients with T2DM. However, further studies are required to validate the findings of this study.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"38 4","pages":"4-7"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare Students' Perceptions About Approaching Spirituality in Their Training and Patient Care: Online, Cross-Sectional Survey. 医学生对在培训和病人护理中处理精神问题的看法:在线横断面调查。
Q3 Medicine Pub Date : 2024-01-01
Tulio L Correa, Isabella Cunha Porsche Ferreira, Gabriel Dias de Oliveira, Ricardo Tavares de Carvalho

Objective: Recent scientific literature points out that religiosity and spirituality play a relevant role in many aspects of life, including health issues. We aimed to evaluate the healthcare students' perceptions about approaching spirituality in their training and patient care in Brazilian universities.

Methods: A cross-sectional observational study was conducted following the STROBE guidelines. Through an anonymous online survey, adult healthcare students from two universities in the city of Pelotas (Brazil) answered a questionnaire about their perceptions on approaching spirituality in their training and patient care. Chi-squared tests were performed, and P ≤ .05 was considered statistically significant.

Results: A total of 163 students were included in the analysis. Most believed that spirituality is important for their training (74.8%) and patient care (84%). However, a minority had had contact with the theme of spirituality during their training (48.5%) or had experienced a situation in which the spiritual aspects of a patient were addressed (47.2%). The students from the private university had more contact with the theme of spirituality in healthcare during their training. Nursing students had significantly more contact with the theme of spirituality in healthcare (P = .008) and had experienced more situations in which the spiritual aspects of a patient were addressed (P = .031) than other students.

Conclusion: Most students believed that the theme of spirituality in healthcare is important for their training and patient care. However, they still had insufficient contact with it during their education. More studies with greater statistical power are needed to better understand this situation globally.

目的:最近的科学文献指出,宗教信仰和灵性在生活的许多方面都发挥着相关作用,包括健康问题。我们的目的是评估巴西大学医学生在培训和病人护理过程中对灵性的看法:我们根据 STROBE 指南开展了一项横断面观察研究。来自巴西佩洛塔斯市两所大学的成年医学生通过匿名在线调查回答了一份问卷,内容涉及他们对在培训和病人护理过程中处理灵性问题的看法。结果显示,共有 163 名学生参与了问卷调查:共有 163 名学生参与了分析。大多数学生认为精神信仰对他们的培训(74.8%)和病人护理(84%)非常重要。然而,少数学生在培训期间接触过灵性主题(48.5%),或经历过涉及病人灵性方面的情况(47.2%)。私立大学的学生在受训期间接触到医疗保健中的灵性主题较多。与其他学生相比,护理专业学生接触医疗保健中的灵性主题的次数明显较多(P = .008),经历过的涉及病人灵性方面的情况也较多(P = .031):大多数学生认为,医疗保健中的灵性主题对他们的培训和病人护理非常重要。结论:大多数学生认为,医疗保健中的灵性主题对他们的培训和病人护理很重要,但他们在接受教育期间与灵性主题的接触仍然不足。为了更好地了解全球的这一情况,需要进行更多具有更大统计能力的研究。
{"title":"Healthcare Students' Perceptions About Approaching Spirituality in Their Training and Patient Care: Online, Cross-Sectional Survey.","authors":"Tulio L Correa, Isabella Cunha Porsche Ferreira, Gabriel Dias de Oliveira, Ricardo Tavares de Carvalho","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Recent scientific literature points out that religiosity and spirituality play a relevant role in many aspects of life, including health issues. We aimed to evaluate the healthcare students' perceptions about approaching spirituality in their training and patient care in Brazilian universities.</p><p><strong>Methods: </strong>A cross-sectional observational study was conducted following the STROBE guidelines. Through an anonymous online survey, adult healthcare students from two universities in the city of Pelotas (Brazil) answered a questionnaire about their perceptions on approaching spirituality in their training and patient care. Chi-squared tests were performed, and P ≤ .05 was considered statistically significant.</p><p><strong>Results: </strong>A total of 163 students were included in the analysis. Most believed that spirituality is important for their training (74.8%) and patient care (84%). However, a minority had had contact with the theme of spirituality during their training (48.5%) or had experienced a situation in which the spiritual aspects of a patient were addressed (47.2%). The students from the private university had more contact with the theme of spirituality in healthcare during their training. Nursing students had significantly more contact with the theme of spirituality in healthcare (P = .008) and had experienced more situations in which the spiritual aspects of a patient were addressed (P = .031) than other students.</p><p><strong>Conclusion: </strong>Most students believed that the theme of spirituality in healthcare is important for their training and patient care. However, they still had insufficient contact with it during their education. More studies with greater statistical power are needed to better understand this situation globally.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"28 1","pages":"4-8"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of a Structured Yoga Intervention Integrated with Routine Care versus Exercise on Pulmonary Function and Quality of Life of Asthma Patients: A Randomized Controlled Trial. 结合常规护理的结构化瑜伽干预与运动对哮喘患者肺功能和生活质量的影响:随机对照试验
Q3 Medicine Pub Date : 2024-01-01
Anshu Yadav, Ranjeeta Kumari, Arun Goel, Girish Sindhwani, Narendra Singh, Rakhee Khanduri

Context: Asthma is a chronic disease and its chronicity demands therapy with minimal harm and a good impact on the quality of life of asthmatics.

Objective: This study evaluates the efficacy of structured yoga intervention integrated with routine care on asthma patients in improving their pulmonary function and quality of life.

Design: The study was a single-blind (outcome assessor) hospital-based randomized controlled trial.

Participants: Adults between 18 to 60 years, diagnosed with mild to moderate asthma as per Global Initiative for Asthma guidelines, with no exacerbation in the past month before screening, were included in the study.

Intervention: A thirty-minute structured yoga intervention was delivered daily by a qualified yoga instructor through a virtual platform.

Outcome measures: Questionnaires were utilized to assess the quality of life, and Breath-o-meter equipment was used to measure peak expiratory flow rate (PEFR). It was tested at baseline and then at 15 days, 45 days, and 90 days, whereas the quality of life was evaluated once a month.

Statistical analysis: Intention to treat analysis was performed to compare the mean outcome between the yoga and control groups using an independent sample t test and repeated measures analysis of variance.

Results: The yoga group significantly improved their PEFR and asthma-related quality of life scores compared to the control group (P < .001). A significant difference (F = 539.72, degree of freedom = 1.1618; P < .001) was detected between PEFR values at several time intervals (baseline, day 15, day 45, day 90) in the intervention group on repeated measures analysis of variance. The difference in quality-of-life scores between yoga and control was also statistically significant (P < .001), with an improvement in the quality-of-life domain of external stimuli.

Conclusion: When combined with normal asthma treatment, the findings of this study show that structured yoga intervention integrated with routine care is more beneficial than traditional breathing exercises in increasing PEFR and quality of life.

背景:哮喘是一种慢性疾病,其长期性要求治疗对哮喘患者的伤害最小,并对其生活质量产生良好影响:本研究评估了结构化瑜伽干预与常规护理相结合对哮喘患者改善肺功能和生活质量的疗效:研究为单盲(结果评估者)医院随机对照试验:研究对象:18 至 60 岁的成年人,根据全球哮喘倡议指南被诊断为轻度至中度哮喘,且在筛查前的一个月内未出现病情加重:干预措施:由一名合格的瑜伽教练通过虚拟平台每天提供三十分钟的结构化瑜伽干预:调查问卷用于评估生活质量,呼吸流量计用于测量呼气峰流速(PEFR)。在基线、15 天、45 天和 90 天时进行测试,而生活质量则每月评估一次:采用独立样本 t 检验和重复测量方差分析对瑜伽组和对照组的平均结果进行了意向治疗分析比较:结果:与对照组相比,瑜伽组的 PEFR 和哮喘相关生活质量评分均有明显改善(P < .001)。通过重复测量方差分析,发现干预组在多个时间间隔(基线、第 15 天、第 45 天、第 90 天)的 PEFR 值之间存在明显差异(F = 539.72,自由度 = 1.1618;P < .001)。瑜伽组和对照组的生活质量评分差异也有统计学意义(P < .001),其中外部刺激领域的生活质量有所改善:结论:本研究结果表明,与常规哮喘治疗相结合的结构化瑜伽干预在提高 PEFR 和生活质量方面比传统呼吸练习更有益处。
{"title":"Efficacy of a Structured Yoga Intervention Integrated with Routine Care versus Exercise on Pulmonary Function and Quality of Life of Asthma Patients: A Randomized Controlled Trial.","authors":"Anshu Yadav, Ranjeeta Kumari, Arun Goel, Girish Sindhwani, Narendra Singh, Rakhee Khanduri","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>Asthma is a chronic disease and its chronicity demands therapy with minimal harm and a good impact on the quality of life of asthmatics.</p><p><strong>Objective: </strong>This study evaluates the efficacy of structured yoga intervention integrated with routine care on asthma patients in improving their pulmonary function and quality of life.</p><p><strong>Design: </strong>The study was a single-blind (outcome assessor) hospital-based randomized controlled trial.</p><p><strong>Participants: </strong>Adults between 18 to 60 years, diagnosed with mild to moderate asthma as per Global Initiative for Asthma guidelines, with no exacerbation in the past month before screening, were included in the study.</p><p><strong>Intervention: </strong>A thirty-minute structured yoga intervention was delivered daily by a qualified yoga instructor through a virtual platform.</p><p><strong>Outcome measures: </strong>Questionnaires were utilized to assess the quality of life, and Breath-o-meter equipment was used to measure peak expiratory flow rate (PEFR). It was tested at baseline and then at 15 days, 45 days, and 90 days, whereas the quality of life was evaluated once a month.</p><p><strong>Statistical analysis: </strong>Intention to treat analysis was performed to compare the mean outcome between the yoga and control groups using an independent sample t test and repeated measures analysis of variance.</p><p><strong>Results: </strong>The yoga group significantly improved their PEFR and asthma-related quality of life scores compared to the control group (P < .001). A significant difference (F = 539.72, degree of freedom = 1.1618; P < .001) was detected between PEFR values at several time intervals (baseline, day 15, day 45, day 90) in the intervention group on repeated measures analysis of variance. The difference in quality-of-life scores between yoga and control was also statistically significant (P < .001), with an improvement in the quality-of-life domain of external stimuli.</p><p><strong>Conclusion: </strong>When combined with normal asthma treatment, the findings of this study show that structured yoga intervention integrated with routine care is more beneficial than traditional breathing exercises in increasing PEFR and quality of life.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"28 2","pages":"10-15"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Impact of Yoga on Peripheral Neuropathy: A Narrative Review. 探索瑜伽对周围神经病变的影响:叙述性综述。
Q3 Medicine Pub Date : 2024-01-01
Mooventhan Aruchunan, Nivethitha Loganathan

Background: Peripheral neuropathies constitute a diverse array of disorders impacting the peripheral nervous system. Despite extensive research on the therapeutic potential of yoga for various health conditions, its specific effects on peripheral neuropathy remain underexplored.

Objective: This review aims to comprehensively investigate the effects, including potential adverse events, of yoga on peripheral neuropathy.

Methods: A systematic literature search was conducted using the PubMed/Medline electronic database from inception to March 5, 2024. The search strategy involved a combination of relevant Medical Subject Heading (MeSH) terms and keywords related to peripheral neuropathy and yoga. The primary outcome measures assessed in the included studies were the improvement in symptoms and clinical indicators of peripheral neuropathy following yoga interventions. Out of 101 articles initially screened, 16 were considered eligible for inclusion in this review.

Results: The synthesized literature suggests that yoga may serve as a beneficial adjunct in the management of diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, lumbar disc herniation-induced neuropathy, Guillain-Barré Syndrome, and Carpal tunnel syndrome. However, caution is warranted as reported instances of yoga asanas precipitate adverse events such as progressive glaucomatous optic neuropathy, bilateral sciatic nerve neuropathy, and acute loss of motor function due to acute ulnar neuropathy.

Conclusions: Yoga holds promise as an adjunctive therapy for the management of peripheral neuropathy. Nonetheless, discrepancies in sample size, type of yoga, and intervention duration across studies underscore the need for larger-scale investigations incorporating standardized long-term yoga interventions and objective outcome measures. To mitigate risks of adverse events, patients should practice yoga under the supervision and guidance of institutionally qualified yoga physicians.

背景:周围神经病是一系列影响周围神经系统的疾病。尽管对瑜伽治疗各种健康状况的潜力进行了广泛研究,但其对周围神经病变的具体影响仍未得到充分探索:本综述旨在全面研究瑜伽对周围神经病变的影响,包括潜在的不良反应:方法:使用 PubMed/Medline 电子数据库对从开始到 2024 年 3 月 5 日的文献进行了系统性检索。搜索策略包括结合与周围神经病变和瑜伽相关的医学主题词(MeSH)和关键词。纳入研究的主要结果评估指标是瑜伽干预后周围神经病变症状和临床指标的改善情况。在初步筛选出的 101 篇文章中,有 16 篇被认为符合纳入本综述的条件:综合文献表明,瑜伽可作为一种有益的辅助疗法,用于治疗糖尿病周围神经病变、化疗引起的周围神经病变、腰椎间盘突出症引起的神经病变、吉兰-巴雷综合征和腕管综合征。然而,由于有报告称瑜伽体式会诱发一些不良事件,如进行性青光眼性视神经病变、双侧坐骨神经病变以及急性尺神经病变导致的急性运动功能丧失,因此必须谨慎:瑜伽有望成为治疗周围神经病的辅助疗法。尽管如此,不同研究在样本量、瑜伽类型和干预持续时间方面存在差异,这表明有必要进行更大规模的调查,纳入标准化的长期瑜伽干预措施和客观的结果测量。为降低不良事件的风险,患者应在有资质的瑜伽医师的监督和指导下练习瑜伽。
{"title":"Exploring the Impact of Yoga on Peripheral Neuropathy: A Narrative Review.","authors":"Mooventhan Aruchunan, Nivethitha Loganathan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Peripheral neuropathies constitute a diverse array of disorders impacting the peripheral nervous system. Despite extensive research on the therapeutic potential of yoga for various health conditions, its specific effects on peripheral neuropathy remain underexplored.</p><p><strong>Objective: </strong>This review aims to comprehensively investigate the effects, including potential adverse events, of yoga on peripheral neuropathy.</p><p><strong>Methods: </strong>A systematic literature search was conducted using the PubMed/Medline electronic database from inception to March 5, 2024. The search strategy involved a combination of relevant Medical Subject Heading (MeSH) terms and keywords related to peripheral neuropathy and yoga. The primary outcome measures assessed in the included studies were the improvement in symptoms and clinical indicators of peripheral neuropathy following yoga interventions. Out of 101 articles initially screened, 16 were considered eligible for inclusion in this review.</p><p><strong>Results: </strong>The synthesized literature suggests that yoga may serve as a beneficial adjunct in the management of diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, lumbar disc herniation-induced neuropathy, Guillain-Barré Syndrome, and Carpal tunnel syndrome. However, caution is warranted as reported instances of yoga asanas precipitate adverse events such as progressive glaucomatous optic neuropathy, bilateral sciatic nerve neuropathy, and acute loss of motor function due to acute ulnar neuropathy.</p><p><strong>Conclusions: </strong>Yoga holds promise as an adjunctive therapy for the management of peripheral neuropathy. Nonetheless, discrepancies in sample size, type of yoga, and intervention duration across studies underscore the need for larger-scale investigations incorporating standardized long-term yoga interventions and objective outcome measures. To mitigate risks of adverse events, patients should practice yoga under the supervision and guidance of institutionally qualified yoga physicians.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"28 2","pages":"16-21"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conversation with Greg Cumberford, Vice President, Science and Regulatory Natures Crops International. 对话国际天然作物组织科学与监管副总裁格雷格-坎伯福德(Greg Cumberford)。
Q3 Medicine Pub Date : 2024-01-01
Greg Cumberford, Sheldon Baker

No Abstract Available.

无摘要。
{"title":"Conversation with Greg Cumberford, Vice President, Science and Regulatory Natures Crops International.","authors":"Greg Cumberford, Sheldon Baker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>No Abstract Available.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"28 3","pages":"56-59"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etiopathogenesis and Management of Prameha Poorvaroopa (Prediabetes), Prameha and Madhumeha (Diabetes Mellitus): An Ancient Perspective. Prameha Poorvaroopa(糖尿病前期)、Prameha 和 Madhumeha(糖尿病)的发病机制和管理:古代视角。
Q3 Medicine Pub Date : 2024-01-01
Jintu Kurian, Ashween Bilagi, Guru Deo

Background: Prameha was identified in 1552 BCE as a Maharoga (major disease), one of the eight grave diseases of Ancient medical history. Initial days of recognition labeled Prameha as a rich man's disease, as found prevalent among people of higher socio-economic background. This fact was thereby linked with the diagnosis of diabetes and the invention of iron in the Iron Age, as wealthy part of the population who initiated consumption of newly harvested rice and wheat were found majorly diagnosed. Gradually, with the knowledge sought from Rigveda, Atharvaveda, Ayurveda, and Samhitas, the causes and types were identified, and further search conducted in Ayurveda resulted in denominating Prameha based on the body constitution and predominant dosha with its etiology in lifestyle and dietary factors, which, in the current scenario is known as diabetes mellitus.

Objective: The objective of the current review is to find out and collate the information sought from published ancient literature on the origin and classification of Prameha with etiological factors.

Method: Articles published between 1982 and 2021 in scientific domain was searched using several keywords in PubMed, Google Scholar, and Google, to find treatment approaches adopted by ancient medics to manage Prameha, Madhumeha, and Prameha Poorvaroopa. Classical literature was reviewed to understand the traditional approaches applied in the context of scientific interpretations. Content of this scriptural review was derived mainly from Rigveda, Atharvaveda, Ayurveda, Sushrutha Samhita, Charaka Samhita, Bhela Samhita, Harita Samhita, and Papillad Samhita.

Summary: The finding of this study brings hope for further studies evidencing advantages in adopting the ancient wisdom while devising a strategy for the management of Prameha from a modern perspective.

背景:Prameha 在公元前 1552 年被确定为 Maharoga(重大疾病),是古代医学史上八大重病之一。最初,人们认为 Prameha 是一种富贵病,在社会经济背景较高的人群中流行。因此,这一事实与糖尿病的诊断和铁器时代铁器的发明联系在一起,因为富裕阶层的人开始食用新收获的稻米和小麦,他们是诊断的主要对象。随着从 Rigveda、Atharvaveda、Ayurveda 和 Samhitas 中获取知识,逐渐确定了糖尿病的病因和类型,并在 Ayurveda 中进行了进一步的搜索,最终根据身体体质和主要的 dosha 及其在生活方式和饮食因素中的病因,将 Prameha 命名为糖尿病:本综述的目的是从已发表的古代文献中寻找并整理有关普拉米哈的起源和分类以及病因的信息:在PubMed、Google Scholar和Google中使用多个关键词搜索1982年至2021年间发表在科学领域的文章,以寻找古代医学家采用的治疗方法来治疗Prameha、Madhumeha和Prameha Poorvaroopa。我们还查阅了经典文献,以了解在科学解释背景下应用的传统方法。总结:本研究的发现为进一步的研究带来了希望,这些研究证明了采用古代智慧的优势,同时从现代角度制定了治疗 Prameha 的策略。
{"title":"Etiopathogenesis and Management of Prameha Poorvaroopa (Prediabetes), Prameha and Madhumeha (Diabetes Mellitus): An Ancient Perspective.","authors":"Jintu Kurian, Ashween Bilagi, Guru Deo","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Prameha was identified in 1552 BCE as a Maharoga (major disease), one of the eight grave diseases of Ancient medical history. Initial days of recognition labeled Prameha as a rich man's disease, as found prevalent among people of higher socio-economic background. This fact was thereby linked with the diagnosis of diabetes and the invention of iron in the Iron Age, as wealthy part of the population who initiated consumption of newly harvested rice and wheat were found majorly diagnosed. Gradually, with the knowledge sought from Rigveda, Atharvaveda, Ayurveda, and Samhitas, the causes and types were identified, and further search conducted in Ayurveda resulted in denominating Prameha based on the body constitution and predominant dosha with its etiology in lifestyle and dietary factors, which, in the current scenario is known as diabetes mellitus.</p><p><strong>Objective: </strong>The objective of the current review is to find out and collate the information sought from published ancient literature on the origin and classification of Prameha with etiological factors.</p><p><strong>Method: </strong>Articles published between 1982 and 2021 in scientific domain was searched using several keywords in PubMed, Google Scholar, and Google, to find treatment approaches adopted by ancient medics to manage Prameha, Madhumeha, and Prameha Poorvaroopa. Classical literature was reviewed to understand the traditional approaches applied in the context of scientific interpretations. Content of this scriptural review was derived mainly from Rigveda, Atharvaveda, Ayurveda, Sushrutha Samhita, Charaka Samhita, Bhela Samhita, Harita Samhita, and Papillad Samhita.</p><p><strong>Summary: </strong>The finding of this study brings hope for further studies evidencing advantages in adopting the ancient wisdom while devising a strategy for the management of Prameha from a modern perspective.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"28 3","pages":"47-51"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in Mind-Body Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1